Observations placeholder
Toradol
Identifier
020217
Type of Spiritual Experience
Background
A description of the experience
Ketorolac or ketorolac tromethamine is a non-steroidal anti-inflammatory drug (NSAID) in the family of heterocyclic acetic acid derivatives, used as an analgesic. It was approved by FDA on 30 November 1989 and introduced as Toradol The ophthalmic (i.e., eye-drop) form was approved by FDA on 9 November 1992 and was introduced as Acular eye drops An intranasal formulation of ketorolac tromethamine was approved by FDA on 14 May 2010 and introduced as Sprix Nasal Spray for short-term management of moderate to moderately severe pain requiring analgesia at the opioid level.
Adverse effects
Concerns over the high incidence of reported side effects with ketorolac trometamol has led to its withdrawal (apart from the ophthalmic formulation) in several countries, while in others its permitted dosage and maximum duration of treatment have been reduced. From 1990 to 1993, 97 reactions with a fatal outcome were reported worldwide
On Jan, 28, 2016: 3,771 people reported to have side effects when taking Toradol. Among them, 34 people (0.90%) have Hallucination.
Time on Toradol when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Feb, 8, 2016: 3,771 people reported to have side effects when taking Toradol. Among them, 65 people (1.72%) have Death.
Time on Toradol when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 90.00% | 0.00% | 10.00% | 0.00% | 0.00% | 0.00% | 0.00% |